Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Ming Cheng Medical & Pharmaceutical Co., Ltd. (now known as Liaoning Hengze Pharmaceutical Co., Ltd.) is a Chinese pharmaceutical distribution company based in Shenyang, Liaoning Province. Founded in 2002, the company specializes in the wholesale and retail of various medical products, including Chinese patent medicines, chemical drug preparations, antibiotics, and biochemical drugs. In 2006, AXM Pharma, Inc. acquired a 51% controlling interest in the company to expand its distribution network in the Chinese market. At the time of acquisition, the company distributed over 5,000 products and held exclusive distribution rights for approximately 100 items. While its parent company, AXM Pharma, underwent a reverse merger and shifted its focus to the agribusiness sector in 2018, Liaoning Ming Cheng (Hengze) continues to operate as a regional distributor in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Ming Cheng Medical & Pharmaceutical.